Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Microbix Biosystems Inc (MBXBF)

Microbix Biosystems Inc (MBXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.62
Trade MBXBF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2680 +4.18%
on 03/05/24
0.2995 -6.78%
on 03/01/24
-0.0232 (-7.67%)
since 02/23/24
3-Month
0.2680 +4.18%
on 03/05/24
0.3278 -14.83%
on 02/14/24
+0.0061 (+2.23%)
since 12/22/23
52-Week
0.1706 +63.66%
on 11/13/23
0.3534 -21.00%
on 05/16/23
+0.0108 (+4.02%)
since 03/23/23

Most Recent Stories

More News
Microbix Executes Substantial QAPs Supply Agreement

Microbix QAPs to Support Molecular & Antigen Test Platforms for Multiple Diseases...

MBX.TO : 0.3650 (-2.67%)
MBXBF : 0.2792 (-0.29%)
Microbix Presenting Test Validation Methods at AACC

Usage of QAPs to Validate Whole Workflow Quality Control of Testing...

MBX.TO : 0.3650 (-2.67%)
MBXBF : 0.2792 (-0.29%)
Microbix Reports Record Results for Q2 Fiscal 2022

Record Q2 Sales of $4.9 million, Q2 Net Earnings of $0.7 million...

MBX.TO : 0.3650 (-2.67%)
MBXBF : 0.2792 (-0.29%)
Microbix Presenting Omicron Test Control Results at CVS

QAPs Supporting Molecular Diagnostic Tests for Dominant COVID-variant...

MBX.TO : 0.3650 (-2.67%)
MBXBF : 0.2792 (-0.29%)
Microbix Presenting at the 2022 Bloom Burton Conference

Healthcare Investor Conference in Toronto on May 2 & 3, 2022...

MBX.TO : 0.3650 (-2.67%)
MBXBF : 0.2792 (-0.29%)
Microbix Presenting Respiratory Virus Controls Data at Two Events

QAPs Supporting Tests That Simultaneously Detect Multiple Respiratory Viruses...

MBX.TO : 0.3650 (-2.67%)
MBXBF : 0.2792 (-0.29%)
Microbix Presenting HPV Product Results at EUROGIN

QAPs Supporting Screening-Tests for High-Risk Human Papilloma Viruses...

MBX.TO : 0.3650 (-2.67%)
MBXBF : 0.2792 (-0.29%)
Microbix Announces Annual and Special Meeting Voting Results

MISSISSAUGA, CANADA, March 31, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and...

MBX.TO : 0.3650 (-2.67%)
MBXBF : 0.2792 (-0.29%)
SNN Network's MicroCap Review Magazine for Q1 2022 Now Online

Venerable Business Publication Focusing Exclusively on MicroCap Companies Resumes Publication in Digital Format LOS ANGELES, CA / ACCESSWIRE / March 1, 2022 / SNN Network, a global multimedia financial...

MBX.TO : 0.3650 (-2.67%)
MBXBF : 0.2792 (-0.29%)
NTE.VN : 0.200 (unch)
NETWF : 0.1600 (-0.68%)
UGE.VN : 0.780 (unch)
UGEIF : 0.5911 (-3.92%)
EAGR.TO : 0.63 (-7.35%)
EAGRF : 0.4435 (+10.88%)
VSBGF : 0.1240 (-5.34%)
VSBY.CN : 0.1600 (unch)
Microbix Announces Issuance of Stock Options

Using Shareholder-Approved Plan to Incentivize and Retain...

MBX.TO : 0.3650 (-2.67%)
MBXBF : 0.2792 (-0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.2907
2nd Resistance Point 0.2853
1st Resistance Point 0.2823
Last Price 0.2792
1st Support Level 0.2739
2nd Support Level 0.2685
3rd Support Level 0.2655

See More

52-Week High 0.3534
Fibonacci 61.8% 0.2836
Last Price 0.2792
Fibonacci 50% 0.2620
Fibonacci 38.2% 0.2404
52-Week Low 0.1706

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar